Assoc Prof Andrew Holden (Auckland city hospital, Auckland, NZ) discusses DISRUPT PAD II and III - Study status and lessons learnt from a real-world registry.
1. What are the DISRUPT PAD II and III studies?
2. Can you describe the IVL technology and how it works?
3. What are the study designs and end points?
4. What were the findings of the studies?
5. What are the key take home messages from these studies?
Interviewer: Mirjam Boros
Videographer: Mike Knight